Define the Role of POT1 Mutation in Genome Instability and Cancer
Define the Role of POT1 Mutation in Genome Instability and Cancer
批准号:
10221642
负责人:
Agnel Sfeir
金额:
$42.67万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-01 至 2023-08-31
关键词:
AddressAffectAttenuatedBiological AssayBypassCRISPR interferenceCancer PatientCell ProliferationCellsChronic Lymphocytic LeukemiaCommon Lymphoid ProgenitorCutaneous T-cell lymphomaDataDefectDevelopmentFosteringFunctional disorderGenetic ScreeningGenomic InstabilityGliomaGoalsHumanImmunocompromised HostLeadLibrariesLymphoma cellMalignant NeoplasmsMissense MutationModelingMonitorMusMutateMutationOncogenesParathyroid AdenomaPatientsPhenotypePrimary NeoplasmProliferatingReportingRoleSignal TransductionT-Cell LymphomaTP53 geneTelomere-Binding ProteinsTestingThymic LymphomaTransplantationTumor Suppressor ProteinsTumor-Derivedattenuationbasecancer cellcancer genomechromosome fusiondriver mutationexperimental studyfunctional genomicsgenome-widein vivomelanomamouse modelneoplastic cellnext generation sequencingnovelnovel strategiespatient stratificationreplication stressstem cellstelomeretherapeutic targettherapeutically effectivetumortumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this proposal is to investigate the mechanism by which alteration in the telomere
binding protein POT1 results in tumorigenesis. Mutations in POT1 (>100) have been associated
with several types of human cancers such as chronic lymphocytic leukemia (CLL), cutaneous T
cell lymphomas (CTCL), mantel cell lymphomas, parathyroid adenomas, gliomas, and
melanomas. Our preliminary data indicate that perturbations in POT1 lead to replication stress at
telomeres and telomere dysfunction. Moreover, we have shown that inhibition of POT1 in the
common lymphoid progenitor cells (CLPs) promotes the formation of thymic lymphomas in mice.
Here we will test our hypothesis that POT1 mutations trigger telomere replication stress which in
turn leads to genome instability and cancer development. In addition, we will address the
mechanism that enables cancer cells with POT1 mutations to bypass telomere replication stress
and proliferate indefinitely. Lastly, we will develop a genetic screen to interrogate POT1 mutations
in vivo and identify driver-mutations. In conclusion, our study will provide an important step
towards identifying novel and effective therapeutic targets to treat an increasing number of cancer
patients with POT1 mutations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the impact and dynamic of mitochondrial common deletion in somatic cells
-
批准号:10826448
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2023
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10379672
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Define the Role of POT1 Mutation in Genome Instability and Cancer
-
批准号:10379657
-
项目类别:
-
资助金额:$20.1万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10576792
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10320939
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2021
-
负责人:Agnel Sfeir
-
依托单位:
Investigating PolQ-mediated alternative NHEJ in breast cancer
-
批准号:10090458
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2019
-
负责人:Agnel Sfeir
-
依托单位:
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac
-
批准号:9298637
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:Agnel Sfeir
-
依托单位:
Deciphering the extra-telomeric function of Rap1, a metabolic regulator counterac
-
批准号:8749789
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2014
-
负责人:Agnel Sfeir
-
依托单位:
海外基金